Industry NewsProteona awards $100,000 in grant funding to multiple myeloma clinical projects aiming to improve treatment outcomes
Product NewsSingle-cell multi-omics confirms high levels of CAR expression and low immunogenic profile of a novel CAR-T product
Industry NewsTwist Bioscience join Proteona in global alliance to protect immunocompromised patients from COVID-19 infection
Industry NewsInnovative AI-driven genomic and proteomic analysis platform to improve cell therapy and immuno-oncology
Product NewsProteona Releases New CAR T Product for Combined Single-Cell Proteomic and Transcriptomic Analysis
